Drupal.behaviors.print = function(context) {window.print();window.close();}>

Mira Dx Launches Ovarian Cancer Risk Test

July 22, 2010

Mira Dx Launches Ovarian Cancer Risk Test

The test, dubbed PreOvar, identifies women at increased risk of developing ovarian cancer based on a genetic variant that affects a key microRNA.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories